$18.180
-0.373 (-2.05%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
SRPT Prediction & Forecast by Similar Chart Analysis
Alphio's SRPT stock price prediction model matches the current Sarepta Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $17.76 (+0.15%). The 1-week path is $17.57 (-0.91%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Sarepta Therapeutics Inc Stock?
Sarepta Therapeutics Inc is currently trading at $17.10, which is below the average analyst price target of $20, indicating potential upside. However, the RSI is at 42.01, suggesting the stock is nearing oversold conditions but not yet in a strong buy zone. The company has shown a gross margin of 85.02% in Q1 2026, indicating strong profitability, but it has faced significant revenue declines, with a 25.81% drop in the past year. The main risk is the hedge fund selling activity, which has increased by 12693.27% over the last quarter, indicating a lack of confidence from institutional investors. Therefore, while there are some positive indicators, the overall sentiment and selling pressure suggest holding off on buying for now.
SRPT stock price ended at $18.18 on Thursday, after losing -2.05%
Sarepta Therapeutics Inc (SRPT) last closed at $17.73, losing -2.48%. These facts feed the 1-day and 1-week SRPT price prediction above.
Analyst Consensus
Sarepta Therapeutics Inc (SRPT): 17 buy, 1 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Sarepta Therapeutics Inc (SRPT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches SRPT, ranked by similarity.
Seasonality analysis for SRPT
Historically the probability of a positive October return for SRPT is 36.51%. January offers the highest probability of a positive month at 54.10%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for SRPT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $53.25 | $57.46 | $69.62 | +224.07% |
| Nov 2026 | $45.36 | $64.90 | $74.86 | +266.05% |
| Dec 2026 | $50.13 | $58.09 | $69.79 | +227.65% |
In 2026, Sarepta Therapeutics Inc (SRPT) is projected to range from $45.36 to $74.86.
Sarepta Therapeutics Inc 2026 monthly forecast
In Oct 2026, Sarepta Therapeutics Inc is projected to average $57.46, with a low of $53.25 and high of $69.62.
In Nov 2026, Sarepta Therapeutics Inc is projected to average $64.90, with a low of $45.36 and high of $74.86.
In Dec 2026, Sarepta Therapeutics Inc is projected to average $58.09, with a low of $50.13 and high of $69.79.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.